Tsh Biopharmoration Financials
| 8432 Stock | TWD 61.20 0.20 0.33% |
Tsh |
Understanding current and past Tsh Biopharmoration Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Tsh Biopharmoration's financial statements are interrelated, with each one affecting the others. For example, an increase in Tsh Biopharmoration's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Tsh Biopharmoration's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of tsh biopharmoration. Check Tsh Biopharmoration's Beneish M Score to see the likelihood of Tsh Biopharmoration's management manipulating its earnings.
Tsh Biopharmoration Stock Summary
Tsh Biopharmoration competes with Pili International, Eastern Media, Oceanic Beverages, Camellia Metal, and Feng Ching. TSH Biopharm Corporation Limited develops, manufactures, and markets drugs for various chronic diseases in Taiwan and China. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited. TSH BIOPHARM is traded on Taiwan OTC Exchange in Taiwan.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0008432006 |
| Business Address | No 3-1, Park |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Major |
| Benchmark | Dow Jones Industrial |
| Website | www.tshbiopharm.com |
| Phone | 886 2 2655 8525 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Tsh Biopharmoration without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Tsh Stock, because this is throwing your money away. Analyzing the key information contained in Tsh Biopharmoration's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Tsh Biopharmoration Key Financial Ratios
There are many critical financial ratios that Tsh Biopharmoration's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that tsh biopharmoration reports annually and quarterly.| Return On Equity | 0.0635 | |||
| Return On Asset | 0.0387 | |||
| Number Of Employees | 80 | |||
| Beta | -0.0266 | |||
| Last Dividend Paid | 1.5 |
Tsh Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tsh Biopharmoration's current stock value. Our valuation model uses many indicators to compare Tsh Biopharmoration value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tsh Biopharmoration competition to find correlations between indicators driving Tsh Biopharmoration's intrinsic value. More Info.tsh biopharmoration is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.61 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for tsh biopharmoration is roughly 1.64 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tsh Biopharmoration's earnings, one of the primary drivers of an investment's value.tsh biopharmoration Systematic Risk
Tsh Biopharmoration's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tsh Biopharmoration volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on tsh biopharmoration correlated with the market. If Beta is less than 0 Tsh Biopharmoration generally moves in the opposite direction as compared to the market. If Tsh Biopharmoration Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one tsh biopharmoration is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tsh Biopharmoration is generally in the same direction as the market. If Beta > 1 Tsh Biopharmoration moves generally in the same direction as, but more than the movement of the benchmark.
Tsh Biopharmoration January 11, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tsh Biopharmoration help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of tsh biopharmoration. We use our internally-developed statistical techniques to arrive at the intrinsic value of tsh biopharmoration based on widely used predictive technical indicators. In general, we focus on analyzing Tsh Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tsh Biopharmoration's daily price indicators and compare them against related drivers.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 8.59 | |||
| Value At Risk | (2.72) | |||
| Potential Upside | 2.04 |
Additional Tools for Tsh Stock Analysis
When running Tsh Biopharmoration's price analysis, check to measure Tsh Biopharmoration's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tsh Biopharmoration is operating at the current time. Most of Tsh Biopharmoration's value examination focuses on studying past and present price action to predict the probability of Tsh Biopharmoration's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tsh Biopharmoration's price. Additionally, you may evaluate how the addition of Tsh Biopharmoration to your portfolios can decrease your overall portfolio volatility.